Search clinical trials for: DA-EPOCH-R

Total 1892 results

Dana-Farber Cancer Institute
Genentech, Inc.

Recruiting

A Phase II Study of Venetoclax in Combination With Dose-adjusted EPOCH-R or R-CHOP for Patients With Richter's Syndrome

Richter Syndrome

United States
Nordic Lymphoma Group
Helsinki University Central Hospital; Aarhus University Hospital

Recruiting

Biomarker Driven Intensified ChemoImmunotherapy With Early CNS Prophylaxis (Bio-CHIC)

Lymphoma, Large B-Cell, Diffuse

Denmark, Norway, Sweden, Finland
Elena N.Parovichnikova

Recruiting

R-BL-M-04 Versus R-(DA)-EPOCH and Autologous Stem Cells Transplantation in Patients With High-Grade B-cell Lymphoma Double-hit (HGBL DH) and High-Grade B-cell Lymphoma Not Otherwise Specified (HGBL NOS)

Lymphoma, High-Grade

Russian Federation
Shandong Provincial Hospital

Recruiting

Orelabrutinib, Rituximab and Combination Chemotherapy in Newly-diagnosed Aggressive B-cell Non-Hodgkin Lymphoma

Mantle Cell Lymphoma | Diffuse Large B-cell Lymphoma | High Grade B-Cell Lymphoma, Not Otherwise Specified | High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements | B-cell NonHodgkin Lymphoma

China
Dong-A ST Co., Ltd.

Recruiting

Clinical Study to Evaluate the Efficacy and Safety of DA-2803 in Chronic Hepatitis B Patients

Hepatitis B

Korea, Republic of
Dong-A ST Co., Ltd.

Completed

Pharmacokinetics and Safety/Tolerability Profiles of DA-2811 in Healthy Subjects (DA-2811)

Healthy

Korea, Republic of
Dong-A ST Co., Ltd.

Not yet recruiting

Phase III Clinical Trial of DA-5212 in Patients With Functional Dyspepsia

Functional Dyspepsia

Korea, Republic of
Dong-A ST Co., Ltd.

Recruiting

A Clinical Trial to Compare the Safety, Tolerability, and PK Properties of DA-5216 and DA-5216-R and to Evaluate the Food Effect on DA-5216.

Healthy

Korea, Republic of
Dong-A ST Co., Ltd.

Completed

Phamacokinetics and Safety Profiles of DA-5213 10mg in Healthy Subjects

Healthy

Korea, Republic of
Dong-A ST Co., Ltd.

Not yet recruiting

Bioequivalence Study Between "DA-5215 Tab" and "DA-5215-R Tab"

Healthy

Korea, Republic of
Stichting Hemato-Oncologie voor Volwassenen Nederland

Active, not recruiting

DA-EPOCH-R Induction Followed by Nivolumab Consolidation in Newly Diagnosed MYC, BCL2 and/or BCL6 Rearranged HGBL (HO152)

Lymphoma, B-Cell | Non Hodgkin Lymphoma | High-grade B-cell Lymphoma | MYC Translocation | BCL-2 Translocation

Netherlands, Belgium
Dong-A ST Co., Ltd.

Completed

Phamacokinetics and Safety Profiles of DA-5210 10/500mg in Healthy Subjects at Fasting State

Healthy

Korea, Republic of
Dong-A ST Co., Ltd.

Completed

Phamacokinetics and Safety Profiles of DA-5210 10/500mg in Healthy Subjects at Fed State

Healthy

Korea, Republic of
Dong-A ST Co., Ltd.

Completed

Phamacokinetics and Safety Profiles of DA-5210 10/1000mg in Healthy Subjects at Fasting State

Healthy

Korea, Republic of
Fudan University

Terminated

Dose-adjusted EPOCH-R in MYC Positive DLBCL

Diffuse Large B-cell Lymphoma

China
Dong-A ST Co., Ltd.

Completed

Phamacokinetics and Safety Profiles of DA-5210 10/1000mg in Healthy Subjects at Fed State

Healthy

Korea, Republic of
Pharmacyclics LLC.
Celgene Corporation

Completed

Ibrutinib and Lenalidomide With Dose Adjusted EPOCH-R in Subjects With Relapsed/Refractory Diffuse Large B-cell Lymphoma

Diffuse Large B Cell Lymphoma Refractory | Diffuse Large B Cell Lymphoma Relapsed

United States
Shandong Provincial Hospital

Recruiting

Study of Zanubrutinib, Rituximab and Combination Chemotherapy in Newly-diagnosed Aggressive B-cell Non-Hodgkin Lymphoma

Mantle Cell Lymphoma | Diffuse Large B Cell Lymphoma | B-cell Non Hodgkin Lymphoma | High Grade B-Cell Lymphoma, Not Otherwise Specified | High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements

China
National Research Center for Hematology, Russia
National Research Center for Hematology

Recruiting

R-Dose-adjusted (DA) - EPOCH-21 Versus R-modified Non-Hodgkin Lymphoma (NHL)-Berlin-Frankfurt-Munster (BFM)-90 Program (mNHL-BFM-90) and Autologous Stem Cells Transplantation (Auto-SCT) in DLBCL With Poor Prognosis

Diffuse Large B-Cell Lymphoma

Russian Federation
American Academy of Pediatrics
University of North Carolina, Chapel Hill; Thrasher Research Fund; RTI International and other collaborators

Completed

Newborn Heart Rate as a Catalyst for Improved Survival

Stillbirth | Neonatal Resuscitation | Neonatal Respiratory Depression | Neonatal Bradycardia

Congo, The Democratic Republic of the
Institute of Hematology & Blood Diseases Hospital
Xian-Janssen Pharmaceutical Ltd.

Not yet recruiting

R-EPOCH in Combination With Ibrutinib for Patients With Classical RT of CLL (BDHRT001)

Richter Transformation

China
Georgetown University
National Cancer Institute (NCI); National Human Genome Research Institute (NHGRI)

Completed

Decision Support Following Genetic Testing for Breast-Ovarian Cancer Susceptibility

Breast Cancer | Ovarian Cancer

United States
Dong-A ST Co., Ltd.

Completed

Pharmacokinetics and Safety Profiles After Administration of DA-5211 and Co-administration of DA-5211-R1 and DA-5211-R2 in Healthy Adult Volunteers

Healthy

Korea, Republic of
Dong-A ST Co., Ltd.

Not yet recruiting

Pharmacokinetics and Safety Profiles After Administration of DA-5218 and Co-administration of DA-5218-R1, DA-5218-R2 and DA-5218-R3 in Healthy Adult Volunteers

Healthy

Korea, Republic of
Dong-A ST Co., Ltd.

Completed

Safety and Efficacy of DA-9805 for Parkinson's Disease

Parkinson's Disease

United States
Myung-gui Choi
Dong-A Pharmaceutical Co., Ltd.

Completed

Study on the Effects of DA-9701 on Gastrointestinal Motility on Healthy Adult Volunteers

Healthy Volunteers

Korea, Republic of
NeuroBo Pharmaceuticals Inc.
Dong-A ST Co., Ltd.

Completed

Study of DA-9801 to Treat Diabetic Neuropathy

Diabetic Neuropathy

United States
Dong-A ST Co., Ltd.

Completed

Study of DA-9801 to Treat Diabetic Neuropathic Pain

Diabetic Neuropathies

Korea, Republic of
Dong-A ST Co., Ltd.

Completed

Phase II Study of DA-6034 Eye Drops in Dry Eye Syndrome (DES)

Dry Eye Syndrome

Korea, Republic of
Dong-A ST Co., Ltd.

Completed

Study to Evaluate the Efficacy and Safety of Intra-articular DA-5202 in Patients With Osteoarthritis of the Knee

Osteoarthritis, Knee

Korea, Republic of
National Cancer Institute (NCI)

Completed

A Randomized Study of EPOCH II Versus EPOCH II and Immunotherapy in Lymphomas

Non Hodgkin's Lymphoma | Hodgkin's Disease

United States
NeuroBo Pharmaceuticals Inc.

Recruiting

First in Human Study in Subjects With Obesity, But Otherwise Healthy

Obesity

United States
Dong-A ST Co., Ltd.

Completed

Phase I Clinical Trial of DA-6886 in Healthy Male Subjects

Irritable Bowel Syndrome

Korea, Republic of
Seoul National University Hospital
Samsung Medical Center; Korea University Guro Hospital; Hanyang University; SMG-SNU... and other collaborators

Completed

Effect of Short-term Motilitone Therapy on Health-related Quality of Life in PD Patients With Gastrointestinal Symptoms (PASS-GI)

Dyspepsia | Parkinson Disease

Korea, Republic of
Fujian Medical University

Active, not recruiting

R-DA-EDOCH Versus R-CEOP90, With/Without Upfront Auto-HSCT in Young Patients With High-risk DLBCL

Diffuse Large B-cell Lymphoma

China
Intuitive Surgical

Recruiting

GENERATE - Next GENERATion of GynEcological Surgery - Robotic Assisted Surgery in Gynecological Indications (GENERATE)

GYN Disorders

Germany
Dong-A ST Co., Ltd.

Completed

Pharmacokinetics and Safety/Tolerability Profiles of DA-5206 Versus Talion® Under Fasting and Fed States in Healthy Male Subjects

Healthy

Korea, Republic of
Dong-A ST Co., Ltd.

Not yet recruiting

Phamacokinetics and Safety Profiles of DA-1229_01 5/1000mg in Healthy Subjects at Fasting State

Healthy

Korea, Republic of
Dong-A Pharmaceutical Co., Ltd.

Completed

A Study to Evaluate the Tolerability, Safety and Pharmacokinetic Characteristics of DA-3803

Infertility | Induction of Ovulation
Dong-A ST Co., Ltd.

Not yet recruiting

Phamacokinetics and Safety Profiles of DA-1229_01 2.5/500mg in Healthy Subjects at Fasting State

Healthy

Korea, Republic of
Dong-A ST Co., Ltd.

Completed

Clinical Study to Evaluate Efficacy and Safety of DA-1229 in Patients With CAVD (DIP-CAVD)

Calcific Aortic Valve Disease

Korea, Republic of
Fundación de investigación HM

Completed

A Cost Effectiveness Analysis of Robotic Versus Laparoscopic Distal Pancreatectomy

Surgery
Indiana University
Patient-Centered Outcomes Research Institute

Completed

Information With or Without Numbers For Optimizing Reasoning About Medical Decisions (INFORM)

Colorectal Cancer Screening

United States
Dong-A ST Co., Ltd.

Unknown

Microtracer Study to Establish Absolute Bioavailability and the Absorption, Metabolism, Excretion of DA-1229

Healthy

United Kingdom
Dong-A ST Co., Ltd.

Not yet recruiting

Phamacokinetics and Safety Profiles of DA-1229_01 5/1000mg in Healthy Subjects at Fed State

Healthy

Korea, Republic of
Dong-A ST Co., Ltd.

Not yet recruiting

Phamacokinetics and Safety Profiles of DA-1229_01 2.5/500mg in Healthy Subjects at Fed State

Healthy

Korea, Republic of
The Third Xiangya Hospital of Central South University

Completed

Evaluation of the Learning Curve in Low Anterior Resection for Rectal Resection With the Two Surgical Robots

Rectal Cancer

China
St. Jude Children's Research Hospital

Recruiting

18F-Fluorodopamine PET Studies of Neuroblastoma and Pheochromocytoma

Neuroblastoma | Pheochromocytoma

United States
Deborah Farr, MD

Recruiting

Safety and Feasibility of Robotic SP Nipple Sparing Mastectomy

Breast Cancer | High Risk of Breast Cancer

United States
VA Office of Research and Development
VA Palo Alto Health Care System; VA Pittsburgh Healthcare System; VA Ann Arbor...

Enrolling by invitation

Project OASIS: Optimizing Approaches to Select Implementation Strategies (OASIS)

Hepatocellular Carcinoma | Cirrhosis

United States

Search clinical trials for: DA-EPOCH-R

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in New Zealand

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations